
Loading, please wait...

Loading, please wait...

Acute Achilles tendon rupture has traditionally been managed surgically because earlier literature suggested lower rerupture rates. This multicentre randomized trial tested whether accelerated functional rehabilitation could narrow that difference. Patients were randomised to surgical repair or nonoperative treatment, with both groups following the same early weight-bearing and range-of-motion programme. Rerupture rates were very low and clinically similar, while strength, motion and functional scores were also broadly comparable. Surgical patients experienced more complications, particularly wound and soft-tissue problems. The study therefore supports nonoperative treatment as a legitimate option when it is paired with a well-structured early functional rehabilitation protocol. The key clinical lesson is that rehabilitation can modify the risk-benefit balance of treatment. Surgery may still be favoured in selected high-demand patients or specific rupture patterns, but the assumption that every acute rupture needs an operation is no longer supported by randomized evidence. For HCPs, patient selection, ultrasound or clinical confirmation of the rupture, early functional bracing and adherence to rehabilitation are central. Treatment discussions should include both the lower operative complication burden of nonoperative care and the need for disciplined follow-up.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Acute Achilles tendon rupture has traditionally been managed surgically because earlier literature suggested lower rerupture rates. This multicentre randomized trial tested whether accelerated functional rehabilitation could narrow that difference. Patients were randomised to surgical repair or nonoperative treatment, with both groups following the same early weight-bearing and range-of-motion programme. Rerupture rates were very low and clinically similar, while strength, motion and functional scores were also broadly comparable. Surgical patients experienced more complications, particularly wound and soft-tissue problems. The study therefore supports nonoperative treatment as a legitimate option when it is paired with a well-structured early functional rehabilitation protocol. The key clinical lesson is that rehabilitation can modify the risk-benefit balance of treatment. Surgery may still be favoured in selected high-demand patients or specific rupture patterns, but the assumption that every acute rupture needs an operation is no longer supported by randomized evidence. For HCPs, patient selection, ultrasound or clinical confirmation of the rupture, early functional bracing and adherence to rehabilitation are central. Treatment discussions should include both the lower operative complication burden of nonoperative care and the need for disciplined follow-up.
Today

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back